Skip to content
AwardedSVKGoodsFramework agreement€124,469

Liek s účinnou látkou laronidáza, 100U/ml con inf 5ml

Published
Published 16 October 2024
Deadline
Closed 20 November 2024

Overview

Liek sa používa na liečbu pacientov s ochorením MPS I (mukopolysacharidóza I). Podáva sa na liečenie neneurologických prejavov tohto ochorenia. Liek je syntetický enzým nazývaný laronidáza. Dokáže nahradiť prírodný enzým, ktorého je pri MPS I nedostatok.

Key details

Country
SVK
Status
Awarded
Category
Goods
Estimated value
€124,469
Procedure
Open
Contract type
Framework agreement
SME suitable
Yes
Published
16 October 2024
Deadline
Closed
Classification (CPV)
Peptic substances

Award outcome

Awarded value
€129,340
Award date
4 February 2025
Contract period
— → 30 January 2026
Winner
  • MED - ART, spol. s r.o.

Contract ending soon? Skim tracks incumbents and flags recompetes early. Book a demo to set up alerts.

Notice history

Every published notice in this contracting process, newest first.

  1. Contract Award Notice

    10 February 2025

  2. Contract Notice

    16 October 2024

Contracting authority

  • Detská fakultná nemocnica s poliklinikou Banská Bystrica

    Procuring entity

    Banská Bystrica, SVK

Get the full picture

AI analysis, bid scoring, and expert strategy for this tender

Skim analyses every tender against your company profile and tells you whether to bid, how to win, and who you are up against.

See which competitors are winning the contracts you're chasing.

15-minute call. We'll pull the win data on your real pipeline and show you what Skim does with it.

Awarded: Liek s účinnou látkou laronidáza, 100U/ml con inf 5ml — won by MED - ART, spol. s r.o. — Skim